Sleep Disorders Trial, Recruiting NCT06363981 Sponsor: Jakub Antczak Condition: Sleep Disorders
Back to Sleep Disorders

Sleep Disorders Trial, Recruiting

NCT06363981
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have been diagnosed with a moderate or severe depressive episode (without psychotic symptoms) at the time of joining the trial, based on standard international diagnostic guidelines.
  • People whose depression severity scores between 20 and 35 points on a standard clinical rating scale called the Hamilton Depression Rating Scale.
  • People who score 8 or more on the Athens Insomnia Scale, a tool used to measure sleep problems.
  • People who score 3 or more on two specific questions (items 4 and 21) of a self-reported depression questionnaire called the Beck Depression Inventory 2 (confirm with trial site for exact question content).
  • People who report having problems with memory and concentration that started around the same time as their depression.

Who may not be able to join:

  • People for whom a brain stimulation technique called transcranial magnetic stimulation (TMS) would be unsafe — for example, those who have metal implants in the head, are pregnant, or have epilepsy.
  • People who are experiencing psychotic symptoms (such as hallucinations or delusions) at the time of joining the trial.
  • People who have had thoughts of suicide or made a suicide attempt in the three months before joining the trial.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Wojciech Korzeniowski, MD, The Education of Research and Development Center, Babinski Clinical Hospital

Phone: +48 12 652 45 20

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Jakub Antczak
Registry
ClinicalTrials.gov
Start date
20 May 2024
Est. completion
1 December 2026

Where this trial is recruiting

🇵🇱 Poland

Primary endpoints

Beck Depression Inventory 2; Froward digit span; Language part of Addenbrooke's Cognitive Examination

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov